EU OKs Difelikefalin for CKD-Associated Pruritus, Generic Diabetes Meds EU OKs Difelikefalin for CKD-Associated Pruritus, Generic Diabetes Meds

CHMP adopts positive opinions for a new drug for pruritis associated with chronic kidney disease, two biosimilar insulins, and a generic form of the DPP-4 inhibitor sitagliptin for type 2 diabetes.International Approvals

Source: Medscape Transplantation Headlines - March 1, 2022 Category: Transplant Surgery Tags: Diabetes & Endocrinology News Source Type: news